Information Provided By: 
Fly News Breaks for March 19, 2015
FOLD
Mar 19, 2015 | 07:59 EDT
JPMorgan believes Amicus's plans announced this morning to file a migalastat new drug application for accelerated approval in the U.S. in the second half of 2015 removes a key overhang on the stock. The firm expects shares to have "meaningful upside" at the open since it believes the bear thesis did not play out. JPMorgan reiterates an Overweight rating on Amicus.
News For FOLD From the Last 2 Days
There are no results for your query FOLD
